News, Culture & Society

Another SEVEN blood clot cases are linked to the AstraZeneca jab in Australia

Australia’s health product watchdog has confirmed another seven cases of blood clots have been linked to the AstraZeneca vaccine in Australia. 

The Therapeutic Goods Administration revealed the new cases in their weekly Covid-19 vaccine safety report on Thursday. 

The authority said three cases were confirmed as a syndrome involving blood clots combined with a low platelet count – while a further four were deemed as ‘probable’ cases. 

The three confirmed cases are a 75-year-old man from Victoria, a 59-year-old man from Queensland, and a 75-year-old man from Western Australia. 

The TGA confirmed two of the patients were treated and released from hospital while the third man is in a stable condition. 

The TGA said on Thursday there have been another three confirmed and four ‘probable’ blood clot cases after the AstraZeneca vaccine with the cases recovering 

Australia could become completely self-reliant with its Covid vaccination program in six months. Pictured: A nurse receives a Covid jab

Australia could become completely self-reliant with its Covid vaccination program in six months. Pictured: A nurse receives a Covid jab

The four ‘probable’ cases are a man, 70, from NSW and three men, 65, 70 and 81, from Victoria. 

The condition, known technically as thrombosis with thrombocytopenia syndrome, is ‘very rare’ according to the TGA with the rates in Australia consistent with other countries. 

Of the 1.8million doses of the AstraZeneca vaccine given in Australia up to Thursday, there have been 18 confirmed blood clot cases.  

Australia has secured 25 million doses of the alternative Moderna coronavirus vaccine from the United States, with the surprise deal also paving the way for local production of mRNA vaccines.

The first 10 million doses of the double-shot jab will be delivered by the end of this year, destined for people under 50.

Another 15 million booster shots are set to arrive next year, designed to guard against emerging COVID-19 strains.

Prime Minister Scott Morrison said it was important to prepare for possible variants of the disease.

‘We’re now well into the phase of dealing with what’s coming next because the pandemic is not going anywhere,’ he said on Thursday.

Labor’s health spokesman Mark Butler wants the government to explain why the deal has taken so long.

The US, Canada, the UK, European Union, Korea, Japan and Israel are already using the jab.

‘Tens and tens of millions of doses of this state-of-the-art vaccine have already been delivered to the people in those countries,’ he told reporters in Canberra.

‘Why do Australians have to wait until the end of this year?’

The Moderna vaccine and booster shot are still subject to approval from the Therapeutic Goods Administration before they can be used in Australia.

Health Minister Greg Hunt said the government had not changed its position on a no-fault compensation scheme for Moderna.

Mr Hunt said the company agreed to the government’s terms.

Moderna is an mRNA – or messenger RNA – vaccine, which teaches cells how to make a protein to trigger an immune response.

Australia does not have the domestic capacity to manufacture such a jab.

But the US biotech company has expressed interest in setting up an Australian base.

Staff prepare Covid vaccines in the pharmacy area at the Olympic Park Vaccination Centre on Monday

Staff prepare Covid vaccines in the pharmacy area at the Olympic Park Vaccination Centre on Monday

‘We look forward to continuing discussions with Australia about establishing potential local manufacturing opportunities,’ Moderna chief executive Stephane Bancel said.

The government will commence an approach to market in coming days for mRNA vaccine manufacturing in Australia.

But health department secretary Brendan Murphy said it was not likely to be established before next year.

Acting Victorian Premier James Merlino said his state was the prime candidate for the site, given it was home to 30,000 professionals working in the sector and had already put money on the table.

‘We are the heart and soul of medical research in this country,’ Mr Merlino told reporters in Melbourne.

‘We’ve also got funding through the breakthrough fund to provide additional support if required.’

In the meantime, the federal government is focused on rolling out the Pfizer and AstraZeneca vaccines.

More than 2.8 million vaccine doses have been administered across the country.

Read more at DailyMail.co.uk